Physician profile
Simin Siddiq
NPI 1255362422
$1,399.71
in general payments reported to CMS, 2019-2025
26 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $159 · 2021: $73.45 · 2022: $249 · 2023: $220 · 2024: $62.49 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $164.47 | 2019-2023 | Andexxa, Farxiga |
| Lilly USA, LLC | $146.11 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $136.19 | 2019-2025 | Ozempic |
| Pfizer INC. | $109.27 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $91.41 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $85.24 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.19 | 2019-2022 | |
| Boston Scientific Corporation | $50.69 | 2021-2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $49.47 | 2021-2025 | |
| Amgen INC. | $45.91 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.06 | 2019-2023 | Lifevest |
| Kiniksa Pharmaceuticals, Ltd. | $42.62 | 2022 | |
| Merck Sharp & Dohme LLC | $37.46 | 2019 | |
| Genentech USA, INC. | $35.57 | 2019 | |
| Impulse Dynamics (USA) INC. | $34.77 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.28 | 2023 | Veozah |
| Abbvie INC. | $25.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.79 | 2025 | Camzyos |
| Atricure, INC. | $23.31 | 2023 | |
| Abbott Laboratories | $22.99 | 2023 | Gallant |
| Glaxosmithkline, LLC. | $22.65 | 2023 | Shingrix, Arexvy |
| Exact Sciences Corporation | $22.39 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $20.11 | 2025 | |
| Intercept Pharmaceuticals, INC. | $20.00 | 2019 | |
| Hikma Pharmaceuticals USA | $17.19 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simin Siddiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.